101 related articles for article (PubMed ID: 20920870)
41. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
[TBL] [Abstract][Full Text] [Related]
42. The GH1/IGF-1 axis polymorphisms and their impact on breast cancer development.
Wagner K; Hemminki K; Försti A
Breast Cancer Res Treat; 2007 Sep; 104(3):233-48. PubMed ID: 17082888
[TBL] [Abstract][Full Text] [Related]
43. Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3.
Harrela M; Koistinen H; Kaprio J; Lehtovirta M; Tuomilehto J; Eriksson J; Toivanen L; Koskenvuo M; Leinonen P; Koistinen R; Seppälä M
J Clin Invest; 1996 Dec; 98(11):2612-5. PubMed ID: 8958225
[TBL] [Abstract][Full Text] [Related]
44. Genetic polymorphisms in the IGFBP3 gene: association with breast cancer risk and blood IGFBP-3 protein levels among Chinese women.
Ren Z; Cai Q; Shu XO; Cai H; Li C; Yu H; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1290-5. PubMed ID: 15298948
[TBL] [Abstract][Full Text] [Related]
45. Novel promoter polymorphism in insulin-like growth factor-binding protein-3: correlation with serum levels and interaction with known regulators.
Deal C; Ma J; Wilkin F; Paquette J; Rozen F; Ge B; Hudson T; Stampfer M; Pollak M
J Clin Endocrinol Metab; 2001 Mar; 86(3):1274-80. PubMed ID: 11238520
[TBL] [Abstract][Full Text] [Related]
46. Functional polymorphisms in the insulin-like binding protein-3 gene may modulate susceptibility to differentiated thyroid carcinoma in Caucasian Americans.
Xu L; Mugartegui L; Li G; Sarlis NJ; Wei Q; Zafereo ME; Sturgis EM
Mol Carcinog; 2012 Oct; 51 Suppl 1(Suppl 1):E158-67. PubMed ID: 22415807
[TBL] [Abstract][Full Text] [Related]
47. Microsatellite polymorphism in the P1 promoter region of the IGF‑1 gene is associated with endometrial cancer.
Kwasniewski W; Gozdzicka-Jozefiak A; Wolun-Cholewa M; Polak G; Sierocinska-Sawa J; Kwasniewska A; Kotarski J
Mol Med Rep; 2016 Jun; 13(6):4950-8. PubMed ID: 27121258
[TBL] [Abstract][Full Text] [Related]
48. IGF1(CA)19 and IGFBP-3-202A/C gene polymorphism and cancer risk: a meta-analysis.
Quan H; Tang H; Fang L; Bi J; Liu Y; Li H
Cell Biochem Biophys; 2014 May; 69(1):169-78. PubMed ID: 24310658
[TBL] [Abstract][Full Text] [Related]
49. The influence of promoter -202 A/C polymorphism (rs2854744) of the IGFBP-3 gene on erectile dysfunction risk and serum levels of IGF-I and IGFBP-3.
Safarinejad MR; Shafiei N; Safarinejad S
J Urol; 2013 Jan; 189(1):374-9. PubMed ID: 23174226
[TBL] [Abstract][Full Text] [Related]
50. Polymorphic CA repeat length in insulin-like growth factor 1 and risk of breast cancer in Iranian women.
Javadi M; Hematti S; Tavassoli M
Med Oncol; 2012 Jun; 29(2):516-20. PubMed ID: 21484083
[TBL] [Abstract][Full Text] [Related]
51. IGF-1, IGFBP-3, and cancer risk.
Schott M; Seissler J; Scherbaum WA
Lancet; 2004 Jul 24-30; 364(9431):325; author reply 326-7. PubMed ID: 15276379
[No Abstract] [Full Text] [Related]
52. IGFBP-3 promoter polymorphism -202A>C (rs2854774) contributes to prostate cancer risk: evidence based on 9,482 subjects.
Ding Q; Shi Y; Fan B; Fan Z; Wang J
Urol Int; 2014; 93(1):100-7. PubMed ID: 24457161
[TBL] [Abstract][Full Text] [Related]
53. IGF gene polymorphisms and breast cancer in African-American and Hispanic women.
Sarkissyan M; Mishra DK; Wu Y; Shang X; Sarkissyan S; Vadgama JV
Int J Oncol; 2011 Jun; 38(6):1663-73. PubMed ID: 21455574
[TBL] [Abstract][Full Text] [Related]
54. Insulin-like growth factor-I gene polymorphism in acne vulgaris.
Tasli L; Turgut S; Kacar N; Ayada C; Coban M; Akcilar R; Ergin S
J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):254-7. PubMed ID: 23457723
[TBL] [Abstract][Full Text] [Related]
55. A promoter polymorphism of the insulin-like growth factor-I gene is associated with left ventricular hypertrophy.
Bleumink GS; Schut AF; Sturkenboom MC; Janssen JA; Witteman JC; van Duijn CM; Hofman A; Stricker BH
Heart; 2005 Feb; 91(2):239-40. PubMed ID: 15657251
[No Abstract] [Full Text] [Related]
56. The impact of IGF-I gene polymorphisms on coronary artery disease susceptibility.
Lin HL; Ueng KC; Wang HL; Chen TP; Yang SF; Chu SC; Hsieh YS
J Clin Lab Anal; 2013 Mar; 27(2):162-9. PubMed ID: 23423640
[TBL] [Abstract][Full Text] [Related]
57. [Association between insulin-like growth factor-1 receptor gene polymorphisms and with susceptibility to adolescent idiopathic scoliosis].
Liu WJ; Qiu Y; Chen ZJ; Liu Z; Shu H; Wang XH; Sun C
Zhonghua Wai Ke Za Zhi; 2009 Dec; 47(23):1813-6. PubMed ID: 20193554
[TBL] [Abstract][Full Text] [Related]
58. IGF1 and IGFBP3 polymorphisms and plasma levels in women.
Jernström H
Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2794; author reply 2795. PubMed ID: 19815640
[No Abstract] [Full Text] [Related]
59. Klotho gene G395A and C1818T polymorphisms in acromegaly: Association with clinical presentation and comorbidities.
Helvaci N; Kabacam S; Dagdelen S; Lay I; Karabulut E; Mut M; Alikasifoglu M; Erbas T
Clin Endocrinol (Oxf); 2021 Apr; 94(4):598-605. PubMed ID: 33296101
[TBL] [Abstract][Full Text] [Related]
60. Association of
Doria PLS; Moscovitz T; Tcherniakovsky M; Fernandes CE; Pompei LM; Wajman M; Nimwegen AV; Haimovich S
Biomed Res Int; 2018; 2018():8704346. PubMed ID: 30643822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
